11 results for "Pariente, Benjamin"
Showing 1–11 · 0.67 seconds · RSS
-
Journal Article Full text
Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste
-
Journal Article Full text
Conservative Treatment of Iatrogenic Ascending Aortic Hematoma Post-Rotablator Coronary Procedure
Background Aortic intramural hematoma due to coronary artery dissection is a rare and serious complication during percutaneous coronary intervention. Case Presentation A 78-year-old female patient was admitted for diagnostic coronarography in the context of stable angina. The coronarography showed…
-
Journal Article Full text
High carriage of adherent invasive E. coli in wildlife and healthy individuals
BACKGROUND: Adherent invasive Escherichia coli (AIEC) are suspected to be involved in the pathogenesis of inflammatory bowel diseases. Since AIEC was first described in 1999, despite important progress on its genomic and immune characterizations, some crucial questions remain unanswered, such as…
-
Journal Article Full text
Cephalic Duodenopancreatectomy for Hyperalgic Duodenal Crohn's Disease Fistulized in the Pancreatic Gland
Upper gastrointestinal (GI) tract involvement in adult Crohn's disease (CD) is rare and severe complications unusual. Stenosis has been reported, but gastroduodenal fistulae are seldom detected during surgery and most of the fistulae are cologastric or ileogastric. In complicated gastroduodenal CD…
-
Journal Article Full text
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
BACKGROUND: Preventing postoperative recurrence (POR) is a major concern in Crohn's disease (CD). While azathioprine is an option, no data is available on ustekinumab efficacy in this situation. AIMS: We compared the effectiveness of ustekinumab versus azathioprine in preventing endoscopic POR in…
-
Journal Article Full text
Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease
Early pathological descriptions of Crohn disease (CD) argued for a potential defect in lymph transport; however, this concept has not been thoroughly investigated. In mice, poor healing in response to infection-induced tissue damage can cause hyperpermeable lymphatic collecting vessels in…
-
Journal Article Full text
Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease
BACKGROUND AND AIMS: The identification of Crohn's disease (CD)‐associated adherent and invasive Escherichia coli (AIEC) is time‐consuming and requires ileal biopsies. We aimed to identify a faster and less invasive methods to detect ileal colonization by AIEC in CD patients. METHODS: CD patients…
-
Journal Article Full text
Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn’s Disease
BACKGROUND & AIMS: The Lémann Index is a tool measuring cumulative structural bowel damage in Crohn’s disease (CD). We reported on its validation and updating. METHODS: This was an international, multicenter, prospective, cross-sectional observational study. At each center, 10 inclusions…
-
Journal Article Full text
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease
BACKGROUND: A clinical decision support tool (CDST) has been validated for predicting treatment effectiveness of vedolizumab (VDZ) in Crohn’s disease. AIM: To assess the utility of this CDST for predicting exposure‐efficacy and disease outcomes. METHODS: Using data from three independent datasets…
-
Journal Article Full text
Development of the Crohn's disease digestive damage score, the Lémann score
Crohn's disease (CD) is a chronic progressive destructive disease. Currently available instruments measure disease activity at a specific point in time. An instrument to measure cumulative structural damage to the bowel, which may predict long-term disability, is needed. The aim of this article is…
-
Journal Article Full text
Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
BACKGROUND & AIMS: We investigated the effects of inducing deep remission in patients with early Crohn’s disease (CD). METHODS: We collected follow-up data from 122 patients (mean age, 31.2 ± 11.3 y) with early, moderate to severe CD (median duration, 0.2 years; interquartile range, 0.1–0.5) who…